The tetracycline-dependent expression system has gained increasing popularity for the expression of any gene of interest. Careful choice of the expression vector has been suggested to exploit the full potential of this system. A novel tetracycline-sensitive expression vector based on a modified mouse mammary tumor virus promoter achieved considerably improved regulatory properties in a series of cell lines tested under transient and stable conditions. Therefore, the applicability of the tetracycline-dependent expression system can be largely enhanced by careful adaptation of the expression vector to the host cell line.
Briefly, the tetracycline-dependent expression system relies on the tetracycline-responsive transcriptional regulatory element of Escherichia coli (tetO) and a bacterial tet-repressor protein. This repressor protein is fused to the C-terminal domain of the protein VP16 from herpes simplex virus which serves as a potent transactivator to stimulate transcription from minimal promoter sequences that are positioned downstream of the tet-operator sequence. Transcription from such a promoter was almost completely suppressed when tetracycline was present in the culture medium, whereas expression is readily achieved by removal of the repressor tetracycline (1, 2) . Beside the ability to tightly control transcription of heterologous genes in transiently or stably transfected cells, the levels of basal expression are critical to study gene products altering cell viability or cell proliferation or to be studied in a temporal fashion due to desensitization or adaptation under continued expression (3) . We used the experience we gained upon development of a cAMP-responsive reporter system with lowest possible levels of basal expression and high induction ratios to circumvent limitations from high basal levels of expression and poor regulatory properties we observed for the original CMV based minimal promoter in various cell lines tested. A modified mouse mammary tumor virus promoter (∆MTV) in which the steroid-responsive region was replaced by multiple copies of a cAMP-responsive element (CRE) proved to confer exquisite sensitivity to cAMP in several cell lines (4 and references therein). We decided, therefore, to transfer the tetO sequences into this promoter and to compare regulatory properties of the new construct p∆MtetO-Luc with those of the CMV-based pUHC13-3 plasmid (1, hereafter called pCMVtetO-Luc) in cell lines from various origin. To create p∆MtetO, the regulatory region of pCMVtetO was excised by HindIII and partial EcoRI digest and inserted into pBluescript SKdigested by EcoRI and HindIII to give pBSK-CMVtetO. A fragment of 157 bp encoding the tetO sequence was released by SmaI and inserted into the plasmid ∆MTVLUC (4) linearized at +256 bp by HindIII and blunted with T4-DNA polymerase to give the construct p∆MtetO-Luc.
As shown in Table 1 , p∆MtetO-Luc-transfected cells displayed 12-100-fold lower basal luciferase levels depending on the cell line and time after transfection. This lower basal luciferase activity resulted in higher induction ratios in all cell lines and at all time points. Though the maximal luciferase activities in the induced condition with p∆MtetO-Luc were lower than the ones obtained in pUHC13-3-transfected cells, the induction ratios were, but for the HeLa cell line, preserved at 24 and 48 h for p∆MtetO-Luc in contrast to pCMVtetO-Luc, which, dependent on the cell type, either decreased (LLC-PK1, SaOs-2, C6) or increased (HeLa, SK-N-MC, CV1).
The basal activities of p∆MtetO-LUC and pCMVtetO-LUC in the absence of tetracycline and the transactivator tTA were undistinguishable from the ones in the presence of tetracycline and the cotransfected transactivator (data not shown). Therefore transactivation by tTA was completely prevented in the presence of tetracycline demonstrating tight control in these cell lines whereas the intrinsic properties of the minimal promoters critically determined the regulatory properties.
To study regulatory properties under stable expression, we transferred the puromycin resistance gene under the control of the SV40 promoter into p∆MtetO-Luc. We further modified the promoter by deleting part of the distal region of the ∆MTV promoter to improve stability in E.coli and added up to five copies of the heptameric tetO sequence to increase inducibility. In comparison to p∆MtetO-Luc, this construct p∆MtetO 5 -Luc displayed a 3-fold higher basal level of expression and an improved 3900-fold induction upon transient transfection into SaOs-2 cells, which resulted in a 10-fold higher level of induced expression (data not shown).
We transfected p∆MtetO 5 -Luc into the cell clones #L5, derived from LLC-PK1 cells, and #S10, derived from SaOs-2 cells, harbouring the tTA-transactivator and investigated 38 individual stable clones of each condition for their regulatory properties. . Cells of the cell clones L22LUC and S12LUC derived from the LLC-PK1 and SaOs-2 cell lines were seeded at 2 × 10 4 cells/well in 12-well plates in the presence of tetracycline and 48 h later the medium was replaced by one containing the indicated concentrations of tetracycline. Luciferase activity after 24 h was standardized with protein concentrations to calculate induction ratios. Table 1 . Regulation of transiently transfected tetracycline-sensitive pCMVtetO and p∆MtetO expression vectors Aliquots of 20 ng of the tetracycline-sensitive expression vectors pCMVtetOLuc and p∆MtetO-Luc were cotransfected with 100 ng pUHD15-1 (encoding the tTA transactivator) into 2-4 × 10 6 cells and plated in 12-well plates in the absence or presence of tetracycline (1 µg/ml). The plasmid pGEM4 served as carrier DNA and the plasmid pCH110, containing the β-galactosidase gene expressed from the SV40 promoter, was used to standardize transfection efficiency between individual samples. Cells were harvested at 24 and 48 h and luciferase activity standardized with β-galactosidase activity. Induction ratios (x-fold) are calculated from standardized basal levels of luciferase activities (std RLU+Tc) and standardized induced levels of luciferase activities (std RLU-Tc). Results are the average from three experiments performed in duplicate. The porcine epithelial cell line LLC-PK1 (ATCC CL 101), the human osteosarcoma cell line SaOs-2 (ATCC HTB 85), the human epitheloid cervix carcinoma cell line HeLa (ATCC CCL2), the human neuroblastoma cell line SK-N-MC (ATTC HTB 10), the rat glial cell line C 6 (ATCC CCL 107) and the green monkey kidney cell line CV-1 (ATCC CCL 70) were grown in DMEM (GIBCO) supplemented with 10% fetal calf serum (GIBCO).
Briefly, we obtained a large number of clones (58%) displaying a several hundred-fold (250-1000-fold) activation in both cell lines and a smaller population (21%) with induction rates exceeding 1000-fold (data not shown). Therefore potent control of gene regulation observed under transient transfections was maintained when p∆MtetO was stably integrated into the tTA-harbouring host genome. The two most promising clones #L22Luc and #S12Luc were tested in detail. Tetracycline dose-response curves ( Fig. 1a and b) revealed a tight control of luciferase expression as expected from previous studies (1) and a complete return to basal levels within 36 h after reexposure to tetracycline (data not shown).
Our results confirm that the regulatory properties of the tetracycline-dependent expression system depend critically on the host cell line and the minimal promoter used for expression. Our novel expression vector offers an alternative on its own in case minimal basal levels of expression are required for study of gene products interfering with cell homeostasis. In addition, under all conditions induction ratios under transient transfection were superior and more stable within 2 days than the original CMV-based expression vector. Though maximal levels of expression with ∆MtetO were lower than those obtained with CMVtetO, these differences could be compensated for by increasing the amount of transfected DNA in transient transfection experiments. These potent regulatory properties were preserved under stable integration into LLC-PK-1 and SaOs-2 cell lines.
Therefore, careful adaptation of the expression vector to the host cell line can significantly contribute to exploit the full range of regulatory properties of tetracycline-controlled gene expression. In this respect, the potent regulatory properties of the novel tetracycline-dependent expression vector in a broad range of cell lines attests to a wide use of the tetracycline-sensitive expression system in future applications.
